|
NR 6/2004
|
|
|
|
|
|
|
|
|
Ocena skuteczno¶ci
preparatu Catalin – kropli ocznych u pacjentów z zaćm±
przedstarcz± i starcz±
Evaluation of effectiveness
of Catalin eyedrops in patients with presenile and senile
cataract
Jarosław Kocięcki, Krzysztof Załęcki, J.
W±siewicz-Rager, Krystyna Pecold
Z Katedry i Kliniki Okulistycznej Akademii Medycznej w Poznaniu
Kierownik: prof. dr hab. n. med. Krystyna Pecold |
|
|
| Summary: |
Aim of the study:
Evaluation of effectiveness of Catalin eye drops in
inhibition of cataract or eventual influence on
regression of actually present opacities.
Patients and method: 72 patients in age over 40
years with initial cortical cataract and visual acuity
better than 0.5 were evaluated. 35 patients were treated
with anticataracous drug Catalin, and 37 received
placebo. All patients were evaluated with a slit-lamp
and modern equipment EAS-1000 (Nidek) before starting
research and after 3, 6, 12, 18 and 24 months of
treatment.
Results: Catalin-eye drops in patients with
cortical cataract showed its effectiveness in inhibition
of lens opacification and its progression especially in
group of patients in age up to 59 years. The increase of
lens opacification in this group was only 1.425% (Catalin),
and in older group (placebo) even 9.228%. Appropriate,
raising effect of the drug can be observed after 18
months of treatment. Catalin-eye drops did not caused
any complications during the study.
Conclusions: 1. Catalin-eye drops used in
patients with senile and presenile cortical cataract is
effective drug in inhibiting lens opacification. 2. The
function of the drug is more obvious in group of younger
patients (up to 59 years of age) in comparison with
older ones. 3. Appropriate, raising effect of the drug
can be observed after 18 months of treatment. 4.
Catalin-eye drops is well tolerated by the patients even
after prolonged application. |
| Słowa kluczowe: |
zaćma, EAS-1000, Catalin,
leki przeciwzaćmowe. |
| Key words: |
cataract, EAS-1000,
Catalin, anticataractous drugs. |
|
|
|
|
|
|
